Financials HPX

Equities

HPX

KYG322191001

Delayed Nyse 09:47:53 2024-04-29 am EDT 5-day change 1st Jan Change
4.02 USD -6.50% Intraday chart for HPX -11.89% -51.15%

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 316.9 312.1 83.71
Enterprise Value (EV) 1 315.8 311.6 84.42
P/E ratio - 33.2 x -63.3 x
Yield - - -
Capitalization / Revenue - - -
EV / Revenue - - -
EV / EBITDA - - -
EV / FCF - -2,134,711,934 x -21,044,662 x
FCF Yield - -0% -0%
Price to Book 63.4 x -16 x -4.59 x
Nbr of stocks (in thousands) 31,625 31,625 8,482
Reference price 2 10.02 9.870 9.870
Announcement Date 3/23/21 4/14/22 7/27/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022
Net sales - - -
EBITDA - - -
EBIT 1 -0.3147 -1.164 -6.634
Operating Margin - - -
Earnings before Tax (EBT) 1 -0.3074 9.395 -3.426
Net income 1 -0.3074 9.395 -3.426
Net margin - - -
EPS - 0.2973 -0.1560
Free Cash Flow - -0.146 -4.011
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 3/23/21 4/14/22 7/27/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022
Net Debt 1 - - 0.71
Net Cash position 1 1.13 0.55 -
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -0.15 -4.01
ROE (net income / shareholders' equity) - -38.9% 18.2%
ROA (Net income/ Total Assets) - -0.29% -3.01%
Assets 1 - -3,283 114
Book Value Per Share 2 0.1600 -0.6200 -2.150
Cash Flow per Share 2 0.0400 0.0200 0.0200
Capex - - -
Capex / Sales - - -
Announcement Date 3/23/21 4/14/22 7/27/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA